These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37924372)

  • 1. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
    Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
    Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards personalized treatment of T2N0 rectal cancer: A systematic review of long-term oncological outcomes of neoadjuvant therapy followed by local excision.
    Peltrini R; Imperatore N; Di Nuzzo MM; Pellino G
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1426-1433. PubMed ID: 35614027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
    Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
    Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
    Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
    Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
    Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
    Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
    Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
    Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
    Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
    Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
    Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 10. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
    Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
    Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
    Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
    Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Outcomes in Total Neoadjuvant Therapy for Rectal Cancer Versus Standard Long-course Chemoradiation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lin W; Li C; Clement EA; Brown CJ; Raval MJ; Karimuddin AA; Ghuman A; Phang PT
    Ann Surg; 2024 Apr; 279(4):620-630. PubMed ID: 38009646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
    Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
    World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group.
    Calmels M; Labiad C; Lelong B; Lefevre JH; Tuech JJ; Benoist S; Mège D; Denost Q; Panis Y
    Colorectal Dis; 2023 Oct; 25(10):1973-1980. PubMed ID: 37679892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches.
    Bach SP;
    Colorectal Dis; 2022 May; 24(5):639-651. PubMed ID: 35114057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-defined T3, clear mesorectal fascia mid-low rectal cancer: is neoadjuvant treatment necessary?
    Zeng Z; Li Z; Luo S; Huang L; Liang Z; Zheng X; Li W; Xiong L; Liu H; Kang L
    J Gastroenterol Hepatol; 2024 May; 39(5):858-867. PubMed ID: 38225773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical T2N0 Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy plus Local Excision.
    Suzuki T; Sadahiro S; Okada K; Miyakita H; Ogimi T; Chan LF; Kamei Y; Yamamoto S
    Oncology; 2023; 101(3):166-172. PubMed ID: 36310019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.